Physician profile
Keith A Harmon
NPI 1396776910
$3,977.30
in general payments reported to CMS, 2019-2025
41 companies · $749 in 2025
The $749 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $187 · 2021: $309 · 2022: $546 · 2023: $761 · 2024: $692 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,020 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,020.06 |
| Education | $181.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $696.52 | 2019-2025 | Xtandi, Veozah |
| Janssen Biotech, INC. | $444.84 | 2019-2025 | Erleada |
| Coloplast Corp | $247.41 | 2021-2025 | Speedicath, Titan |
| Pfizer INC. | $230.72 | 2019-2025 | |
| Abbvie INC. | $214.37 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $201.34 | 2019-2025 | |
| Amgen INC. | $167.53 | 2019-2023 | Prolia, Xgeva |
| Procept Biorobotics Corporation | $138.91 | 2024 | Aquabeam System |
| Urogen Pharma, INC. | $132.80 | 2022-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $127.08 | 2023-2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $124.61 | 2024-2025 | Cvac Aspiration System |
| Tolmar, INC. | $103.15 | 2024-2025 | Eligard |
| Myovant Sciences INC. | $92.90 | 2021-2022 | |
| 180 Medical, INC. | $75.84 | 2019-2023 | |
| Olympus America INC. | $75.00 | 2022-2025 | Itind System |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $72.28 | 2019-2021 | |
| Teleflex LLC | $71.69 | 2022-2023 | Urolift |
| Axonics, INC. | $56.11 | 2023-2024 | Axonics |
| Merck Sharp & Dohme LLC | $52.80 | 2022-2023 | Lynparza, Keytruda |
| Medtronic, INC. | $52.57 | 2022-2023 | Interstim |
| Mimedx Group, INC. | $48.06 | 2025 | |
| Endo Pharmaceuticals INC. | $47.56 | 2019-2023 | Xiaflex |
| Boston Scientific Corporation | $45.97 | 2022-2023 | Ams 800 Artificial Urinary Sphincter |
| Gilead Sciences, INC. | $43.53 | 2022 | |
| Progenics Pharmaceuticals, INC. | $38.34 | 2025 | |
| Palette Life Sciences, INC. | $33.85 | 2022 | |
| Telix Pharmaceuticals | $33.74 | 2024-2025 | Illuccix |
| Agiliti Surgical, INC. | $33.56 | 2023 | Sonablate |
| Millicent US INC | $32.60 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $32.26 | 2021 | |
| Cycle Pharmaceuticals INC | $29.01 | 2024 | Tiopronin |
| Aytu Biopharma, INC. | $22.80 | 2019 | |
| Bioprotect Medical, INC. | $22.30 | 2025 | Bioprotect Balloon Implant System |
| Angiodynamics, INC. | $21.14 | 2025 | Nanoknife |
| Dendreon Pharmaceuticals LLC | $19.21 | 2019 | |
| Hollister Incorporated | $18.75 | 2022 | |
| Accord Healthcare, INC. | $17.87 | 2022 | |
| Immunitybio, INC. | $17.46 | 2024 | |
| Ferring Pharmaceuticals INC. | $16.22 | 2024 | Adstiladrin |
| Mission Pharmacal Company | $13.69 | 2022 | |
| Blue Earth Diagnostics | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.